
Krishnendu Roy
@krishroylab
Bruce and Bridgitt Evans Dean of Engineering; University Distinguished Professor; Vanderbilt University.
Opinions are my own, Re-tweets are not endorsements.
ID: 807773527
http://sites.gatech.edu/roylab 06-09-2012 23:09:24
4,4K Tweet
3,3K Followers
788 Following

The ribbon has been cut and Vanderbilt Lab for Immersive AI Translation has officially opened its doors! Bennett Landman, VALIANT founder was joined by his team, along with Provost C. Cybele Raver (VU Provost Office), and Dean of the Vanderbilt University School of Engineering, Krish Roy (Krishnendu Roy).

Dr Eden Tanner Immunoengineering Lab Brittany Givens Rassoolkhani, PhD Daniel Gonzales Simms Lab of Functional Biomaterials John Martin Dean Roy introducing our grand finale keynote talk by Georgia Techās Andres Garcia on synthetic hydrogels for regenerative medicine. Krishnendu Roy GarciaLabGT







At Vanderbilt University, researchers in the Lab for Immersive AI Translation are using AI to unlock new insights from medical imagingāimproving diagnoses, tracking health over time, and shaping a more proactive future for patient care. news.vanderbilt.edu/2025/04/14/seeā¦

So proud of one of my OG PhD graduate from the Krishnendu Roy, from my Texas BME days - congrats Sabia! Rice University Bioengineering

A new Science Advances study identifies a neuroimmune pathway for treating sepsis, finding that dopamine inhibits expression of a critical regulator of immunometabolism. This suggests that pramipexole, a dopamine agonist, could effectively treat lethal infections.



š Grace Ann Jones, pictured with Dean @krishroylab, is the 2025 Founderās Medalist for the School of Engineering at Vanderbilt University! š She is graduating with a B.S. in Engineering Science, Chemistry, and Math, plus minors in Scientific Computing and Business. Congratulations! š


Dr. Jonathan Brunger's team at Vanderbilt BME presents a method for cell-guided differentiation using the synthetic Notch receptor platform to regulate SHH production and subsequent cell fate specification. Check it out! š bit.ly/3Sact4L





Researchers led by Vanderbilt University School of Engineering associate prof. John T. Wilson, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. Read more: ow.ly/VA5250WaQR0


Fascinating to see patient data about this in #nsclc. Here is mechanistic evidence in mice and potential explanation, published recently. nature.com/articles/s4159⦠anti- PDL-1 treatment correlated to the circadian levels of #MDSCs in CRC. Sandip Patel MD FASCO UC San Diego Health Dr. Amy C. Moore